Case Report
Published on 04 Jul 2022
Case Report: Recombinant Human Endostatin Plus Chemotherapy for Epidermal Growth Factor Receptor-Negative Miliary Lung Adenocarcinoma
in Thoracic Oncology
- 1,490 views
- 4 citations
Case Report
Published on 04 Jul 2022
in Thoracic Oncology
Original Research
Published on 01 Jul 2022
in Thoracic Oncology
Review
Published on 30 Jun 2022
in Thoracic Oncology
Original Research
Published on 30 Jun 2022
in Thoracic Oncology
Clinical Trial
Published on 30 Jun 2022
in Thoracic Oncology
Original Research
Published on 29 Jun 2022
in Thoracic Oncology
Systematic Review
Published on 28 Jun 2022
in Thoracic Oncology
Original Research
Published on 28 Jun 2022
in Thoracic Oncology
Original Research
Published on 27 Jun 2022
in Thoracic Oncology
Original Research
Published on 27 Jun 2022
in Thoracic Oncology
Systematic Review
Published on 24 Jun 2022
in Thoracic Oncology
Original Research
Published on 23 Jun 2022
in Thoracic Oncology
Original Research
Published on 23 Jun 2022
in Thoracic Oncology
Original Research
Published on 23 Jun 2022
in Thoracic Oncology
Original Research
Published on 22 Jun 2022
in Thoracic Oncology
Original Research
Published on 22 Jun 2022
in Thoracic Oncology